Browse > Article

New Players in the BRCA1-mediated DNA Damage Responsive Pathway  

Kim, Hongtae (Department of Therapeutic Radiology, Yale University School of Medicine)
Chen Junjie (Department of Therapeutic Radiology, Yale University School of Medicine)
Publication Information
Molecules and Cells / v.25, no.4, 2008 , pp. 457-461 More about this Journal
Abstract
DNA damage checkpoint is an important self-defense mechanism for the maintenance of genome stability. Defects in DNA damage signaling and repair lead to various disorders and increase tumor incidence in humans. In the past 10 years, we have identified many components involved in the DNA damage-signaling pathway, including the product of breast cancer susceptibility gene 1 (BRCA1). Mutations in BRCA1 are associated with increased risk of breast and ovarian cancers, highlighting the importance of this DNA damage-signaling pathway in tumor suppression. While it becomes clear that BRCA1 plays a crucial role in the DNA damage responsive pathway, exactly how BRCA1 receives DNA damage signals and exerts its checkpoint function has not been fully addressed. A series of recent studies reported the discovery of many novel components involved in DNA damage-signaling pathway. These newly identified checkpoint proteins, including RNF8, RAP80 and CCDC98, work in concern in recruiting BRCA1 to DNA damage sites and thus regulate BRCA1 function in G2/M checkpoint control. This review will summarize these recent findings and provide an updated view of the regulation of BRCA1 in response to DNA damage.
Keywords
BRCA1; CCDC98; G2/M Checkpoint; RAP80; RNF8; UIM;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By Web Of Science : 20  (Related Records In Web of Science)
연도 인용수 순위
1 Couch, F.J., DeShano, M.L., Blackwood, M.A., Calzone, K., Stopfer, J., Campeau, L., Ganguly, A., Rebbeck, T., and Weber, B.L. (1997). BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N. Engl. J. Med. 336, 1409-1415   DOI   ScienceOn
2 Deng, C.X. (2002). Roles of BRCA1 in centrosome duplication. Oncogene 21, 6222-6227   DOI   ScienceOn
3 Huen, M.S., Grant, R., Manke, I., Minn, K., Yu, X., Yaffe, M.B., and Chen, J. (2007). RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly. Cell 131, 901-914   DOI   ScienceOn
4 Mailand, N., Bekker-Jensen, S., Faustrup, H., Melander, F., Bartek, J., Lukas, C., and Lukas, J. (2007). RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins. Cell 131, 887-900   DOI   ScienceOn
5 Manke, I.A., Lowery, D.M., Nguyen, A., and Yaffe, M.B. (2003). BRCT repeats as phosphopeptide-binding modules involved in protein targeting. Science 302, 636-639   DOI
6 Stucki, M., Clapperton, J.A., Mohammad, D., Yaffe, M.B., Smerdon, S.J., and Jackson, S.P. (2005). MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell 123, 1213-1226   DOI   ScienceOn
7 Zhou, B.B., and Elledge, S.J. (2000). The DNA damage response: putting checkpoints in perspective. Nature 408, 433-439   DOI   ScienceOn
8 Kim, H., Chen, J., and Yu, X. (2007a). Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response. Science 316, 1202-1205   DOI
9 Kim, H., Huang, J., and Chen, J. (2007b). CCDC98 is a BRCA1-BRCT domain-binding protein involved in the DNA damage response. Nat. Struct. Mol. Biol. 14, 710-715   DOI   ScienceOn
10 Hashizume, R., Fukuda, M., Maeda, I., Nishikawa, H., Oyake, D., Yabuki, Y., Ogata, H., and Ohta, T. (2001). The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. J. Biol. Chem. 276, 14537-14540   DOI   ScienceOn
11 Kolas, N.K., Chapman, J.R., Nakada, S., Ylanko, J., Chahwan, R., Sweeney, F.D., Panier, S., Mendez, M., Wildenhain, J., Thomson, T.M., et al. (2007). Orchestration of the DNAdamage response by the RNF8 ubiquitin ligase. Science 318, 1637-1640   DOI
12 Zhao, G.Y., Sonoda, E., Barber, L.J., Oka, H., Murakawa, Y., Yamada, K., Ikura, T., Wang, X., Kobayashi, M., Yamamoto, K., et al. (2007). A critical role for the ubiquitin-conjugating enzyme Ubc13 in initiating homologous recombination. Mol. Cell 25, 663-675   DOI   ScienceOn
13 Yu, X., and Chen, J. (2004). DNA damage-induced cell cycle checkpoint control requires CtIP, a phosphorylation-dependent binding partner of BRCA1 C-terminal domains. Mol. Cell Biol. 24, 9478-9486   DOI   ScienceOn
14 Hahn, W.C., and Weinberg, R.A. (2002). Rules for making human tumor cells. N. Engl. J. Med. 347, 1593-1603   DOI
15 Chen, A., Kleiman, F.E., Manley, J.L., Ouchi, T., and Pan, Z.Q. (2002). Autoubiquitination of the BRCA1*BARD1 RING ubiquitin ligase. J. Biol. Chem. 277, 22085-22092   DOI   ScienceOn
16 Cantor, S.B., Bell, D.W., Ganesan, S., Kass, E.M., Drapkin, R., Grossman, S., Wahrer, D.C., Sgroi, D.C., Lane, W.S., Haber, D.A., et al. (2001). BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 105, 149-160   DOI   ScienceOn
17 Bekker-Jensen, S., Lukas, C., Melander, F., Bartek, J., and Lukas, J. (2005). Dynamic assembly and sustained retention of 53BP1 at the sites of DNA damage are controlled by Mdc1/NFBD1. J. Cell Biol. 170, 201-211   DOI   ScienceOn
18 Takano, Y., Adachi, S., Okuno, M., Muto, Y., Yoshioka, T., Matsushima- Nishiwaki, R., Tsurumi, H., Ito, K., Friedman, S.L., Moriwaki, H., et al. (2004). The RING finger protein, RNF8, interacts with retinoid X receptor alpha and enhances its transcription-stimulating activity. J. Biol. Chem. 279, 18926-18934   DOI   ScienceOn
19 Liu, Z., Wu, J., and Yu, X. (2007). CCDC98 targets BRCA1 to DNA damage sites. Nat. Struct. Mol. Biol. 14, 716-720   DOI   ScienceOn
20 Su, T.T. (2006). Cellular responses to DNA damage: one signal, multiple choices. Annu. Rev. Genet. 40, 187-208   DOI   ScienceOn
21 Deng, C.X., and Brodie, S.G. (2000). Roles of BRCA1 and its interacting proteins. Bioessays 22, 728-737   DOI   ScienceOn
22 Ito, K., Adachi, S., Iwakami, R., Yasuda, H., Muto, Y., Seki, N., and Okano, Y. (2001). N-Terminally extended human ubiquitin- conjugating enzymes (E2s) mediate the ubiquitination of RING-finger proteins, ARA54 and RNF8. Eur. J. Biochem. 268, 2725-2732   DOI   ScienceOn
23 Rouse, J., and Jackson, S.P. (2002). Interfaces between the detection, signaling, and repair of DNA damage. Science 297, 547-551   DOI
24 Scully, R., and Livingston, D.M. (2000). In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408, 429-432   DOI   ScienceOn
25 Yan, Z., Kim, Y.S., and Jetten, A.M. (2002). RAP80, a novel nuclear protein that interacts with the retinoid-related testisassociated receptor. J. Biol. Chem. 277, 32379-32388   DOI   ScienceOn
26 Wang, B., Matsuoka, S., Ballif, B.A., Zhang, D., Smogorzewska, A., Gygi, S.P., and Elledge, S.J. (2007). Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response. Science 316, 1194-1198   DOI
27 Lou, Z., Minter-Dykhouse, K., Franco, S., Gostissa, M., Rivera, M.A., Celeste, A., Manis, J.P., van Deursen, J., Nussenzweig, A., Paull, T.T., et al. (2006). MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals. Mol. Cell 21, 187-200   DOI   ScienceOn
28 Falck, J., Coates, J., and Jackson, S.P. (2005). Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature 434, 605-611   DOI   ScienceOn
29 Yu, X., Chini, C.C., He, M., Mer, G., and Chen, J. (2003). The BRCT domain is a phospho-protein binding domain. Science 302, 639-642   DOI
30 Wang, B., and Elledge, S.J. (2007). Ubc13/Rnf8 ubiquitin ligases control foci formation of the Rap80/Abraxas/Brca1/Brcc36 complex in response to DNA damage. Proc. Natl. Acad. Sci. USA 104, 20759-20763
31 Ford, D., Easton, D.F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D.T., Weber, B., Lenoir, G., Chang- Claude, J., et al. (1998). Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium. Am. J. Hum. Genet. 62, 676-689   DOI   ScienceOn
32 Venkitaraman, A.R. (2002). Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108, 171-182   DOI   ScienceOn
33 Sobhian, B., Shao, G., Lilli, D.R., Culhane, A.C., Moreau, L.A., Xia, B., Livingston, D.M., and Greenberg, R.A. (2007). RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites. Science 316, 1198-1202   DOI